{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreibywqa7dlm6iuglt55kbot57bdsahhkubucfgfv5b22skk6vrtbje",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mgvnp4bgtty2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreihtgoorop2pk4zvcx2cd73a2dlogzjf6ip7xzzp3quf57ixgvw2m4"
    },
    "mimeType": "image/jpeg",
    "size": 71764
  },
  "path": "/news/2026-03-fda-fast-track-nipocalimab-lupus.html",
  "publishedAt": "2026-03-12T19:50:02.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "Johnson & Johnson's nipocalimab has been granted U.S. Food and Drug Administration Fast Track designation as a potential treatment for adults with systemic lupus erythematosus (SLE).",
  "title": "FDA provides fast track designation to nipocalimab for systemic lupus erythematosus"
}